The tumor-immune cells microenvironment augments PD-L1 expression with pro-inflammatory cytokines, such as IFN-γ, tumor necrosis factor α (TNF-α), IL-10, interleukin-1 (IL-1) and interleukin-6 (IL-6) (100). The gene discussed is IFNG; the disease is neoplasm.